These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1586507)
21. Tumors after radiotherapy for thyroid cancer. A case-control study within a cohort of thyroid cancer patients. Hall P; Holm LE; Lundell G; Rudén BI Acta Oncol; 1992; 31(4):403-7. PubMed ID: 1632973 [TBL] [Abstract][Full Text] [Related]
22. [Possible sequelae of the action of radioactive iodine in man]. Il'in LA; Arkhangel'skaia GV Med Radiol (Mosk); 1973 Aug; 18(8):66-80. PubMed ID: 4801844 [No Abstract] [Full Text] [Related]
23. Weighing shadows: can meta-analysis help define the risk-benefit ratio of RAI treatment for low-risk thyroid cancer patients? Schneider AB; Viana MA; Ron E Thyroid; 2009 May; 19(5):435-6. PubMed ID: 19415992 [No Abstract] [Full Text] [Related]
24. Leukemia developing after 131I treatment for thyroid cancer in a patient with Werner's syndrome: molecular and cytogenetic studies. Takemoto Y; Hata T; Kamino K; Mitsuda N; Miki T; Kawagoe H; Ogihara T Intern Med; 1995 Sep; 34(9):863-7. PubMed ID: 8580557 [TBL] [Abstract][Full Text] [Related]
25. [Four cases of hematologic malignancy following radioactive iodine therapy for thyroid cancer]. Im M; Lee JK; Hong YJ; Hong SI; Kang HJ; Na II; Ryoo BY; Cheon GJ; Lee HN; Chang YH Korean J Lab Med; 2008 Dec; 28(6):425-9. PubMed ID: 19127106 [TBL] [Abstract][Full Text] [Related]
26. Chronic myeloid leukaemia following radioiodine therapy for carcinoma thyroid. Bundi RS; Scott JS; Halnan KE Br J Radiol; 1977 Jan; 50(589):61-4. PubMed ID: 264404 [No Abstract] [Full Text] [Related]
27. New horizons for therapeutic nuclear medicine in 1981. Beierwaltes WH J Nucl Med; 1981 Jun; 22(6):549-54. PubMed ID: 7229726 [TBL] [Abstract][Full Text] [Related]
28. [A case of myelogenous leukemia occurring 8 years following 131I therapy for hyperthyroidism (author's transl)]. Sugiyama H; Shimada H; Senzaki S; Takahashi T; Horiuchi T; Hoshino T Rinsho Ketsueki; 1982 Mar; 23(3):356-64. PubMed ID: 6955535 [No Abstract] [Full Text] [Related]
29. Subsequent malignancies in patients treated with 131-iodine for thyroid cancer. Glanzmann C Strahlenther Onkol; 1992 Jun; 168(6):337-43. PubMed ID: 1621212 [TBL] [Abstract][Full Text] [Related]
30. Secondary chronic myelogenous leukemia after chemotherapy followed by adjuvant radiotherapy for small cell lung cancer. Waller CF; Fetscher S; Lange W Leuk Res; 1999 Oct; 23(10):961-4. PubMed ID: 10573143 [TBL] [Abstract][Full Text] [Related]
32. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer. Garsi JP; Schlumberger M; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henry-Amar M; Bardet S; Rubino C; De Vathaire F Clin Endocrinol (Oxf); 2009 Dec; 71(6):880-3. PubMed ID: 19250267 [TBL] [Abstract][Full Text] [Related]
33. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer. Lassmann M; Luster M; Hänscheid H; Reiners C J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368 [No Abstract] [Full Text] [Related]
34. Hyperparathyroidism after treatment with radioactive iodine: not only a coincidence? Bondeson AG; Bondeson L; Thompson NW Surgery; 1989 Dec; 106(6):1025-7. PubMed ID: 2588108 [TBL] [Abstract][Full Text] [Related]
35. Kinetics of large therapy doses of 131I in patients with thyroid cancer. Singh B; Sharma SM; Patel MC; Raghavendran KV; Berman M J Nucl Med; 1974 Aug; 15(8):674-8. PubMed ID: 4841821 [No Abstract] [Full Text] [Related]